As of 2026-09-23, the Fair Value of Fate Therapeutics Inc (FATE) is -5.40 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 2.58 USD, the upside of Fate Therapeutics Inc is -309.49%.
With the market price of 2.58 USD and our fair value calculation, Fate Therapeutics Inc (FATE) is not a good investment. Investing in FATE stocks now will result in a potential loss of 309.49%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -212.15 | -281.72 | -160.93 | -186.26 | -136.31 | -195.47 |
| YoY growth | -22.35% | -32.79% | 42.88% | -15.74% | 26.82% | -0.24% |
| Market Cap (mil) | 300.72 |
| P/E | |
| Forward P/E |
| EPS | -1.08 |
| Avg earnings growth rate | -0.24% |
| TTM earnings | -126.00 |